NCT05477823View on ClinicalTrials.gov

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 8, 2023

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Prostate Cancer
Interventions
RADIATION

External beam radiation therapy

Standard of care EBRT

RADIATION

Prostate brachytherapy boost

Standard of care BTX

DRUG

Androgen deprivation therapy

Standard of care ADT

DIAGNOSTIC_TEST

Positron emission tomography (PET)/magnetic resonance imaging (MRI)

Pelvic PET scanning with tracer will take approximately 45 minutes. This will be followed by the injection of a contrast agent followed by whole body PET/MRI scanning which will take approximately 30 minutes.

Trial Locations (1)

53705

RECRUITING

University of Wisconsin, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER